GlassScriptPhysician profile
Alan Steven Nasar
NPI 1841278116
$1,444.99
in general payments reported to CMS, 2019-2025
15 companies · $198 in 2025
The $198 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $184 · 2021: $302 · 2022: $124 · 2023: $62.26 · 2024: $337 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $597.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $271.97 | 2019-2025 | Gel-One Cross-Linked Hyaluronate |
| Depuy Synthes Sales INC. | $214.71 | 2019-2024 | Orthovisc, Monovisc, Dynacord |
| Bioventus LLC | $204.42 | 2019-2021 | |
| Smith+Nephew, INC. | $139.64 | 2022-2024 | Or3o Dual Mobility, R3 Acetabular, Polarstem |
| Radius Health, INC. | $124.93 | 2024 | Tymlos |
| Collegium Pharmaceutical, INC. | $117.79 | 2024-2025 | Belbuca |
| Spr Therapeutics, INC | $81.53 | 2021 | |
| Stryker Corporation | $73.58 | 2023-2024 | Motionsense Digital Goniometer, Mako |
| Biotronik Nro, INC. | $53.51 | 2023-2025 | Biotronik, Prospera |
| Acumed LLC | $47.39 | 2019 | |
| Nalu Medical, INC. | $37.15 | 2025 | Nalu Neurostimulation System |
| Seapearl East, INC | $29.32 | 2025 | |
| Ethicon US, LLC | $17.04 | 2019 | |
| Endo USA, INC. | $16.42 | 2025 | Xiaflex |
| Averitas Pharma INC. | $15.59 | 2024 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Nasar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.